HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

John I Lew Selected Research

Parathyroidectomy

12/2015Intraoperative Parathormone Monitoring Mitigates Age-Related Variability in Targeted Parathyroidectomy for Patients with Primary Hyperparathyroidism.
7/2015Long-term effectiveness of localization studies and intraoperative parathormone monitoring in patients undergoing reoperative parathyroidectomy for persistent or recurrent hyperparathyroidism.
9/2013Efficacy of localization studies and intraoperative parathormone monitoring in the surgical management of hyperfunctioning ectopic parathyroid glands.
6/2012Postoperative hungry bone syndrome in patients with secondary hyperparathyroidism of renal origin.
12/2011Hypercalcemic crisis in the era of targeted parathyroidectomy.
12/2011Normocalcemic parathormone elevation after successful parathyroidectomy: long-term analysis of parathormone variations over 10 years.
1/2011Role of SPECT and SPECT/CT in the Surgical Treatment of Primary Hyperparathyroidism.
7/2010Operative failure in the era of focused parathyroidectomy: a contemporary series of 845 patients.
12/2009Focused parathyroidectomy guided by intra-operative parathormone monitoring does not miss multiglandular disease in patients with sporadic primary hyperparathyroidism: a 10-year outcome.
7/2009Sporadic primary hyperparathyroidism in young individuals: different disease and treatment?
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


John I Lew Research Topics

Disease

13Primary Hyperparathyroidism
12/2015 - 07/2006
5Hyperparathyroidism
07/2015 - 07/2008
5Neoplasms (Cancer)
06/2015 - 09/2008
4Thyroid Nodule (Nodule, Thyroid)
05/2013 - 09/2008
3Hypercalcemia (Milk Alkali Syndrome)
07/2010 - 12/2007
2Thyroid Neoplasms (Thyroid Cancer)
09/2013 - 05/2013
2Parathyroid Neoplasms (Parathyroid Neoplasm)
12/2011 - 07/2009
1Endocrine Gland Neoplasms (Cancer, Endocrine)
06/2015
1Lymphoma (Lymphomas)
09/2013
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
09/2013
1Thyroid Diseases (Thyroid Disease)
09/2012
1Spasm (Spasms)
06/2012
1Hypocalcemia
06/2012
1Secondary Hyperparathyroidism
06/2012
1Pain (Aches)
06/2012
1Carcinoma (Carcinomatosis)
07/2011
1Rickets (Rachitis)
07/2009
1Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
07/2009
1Parathyroid Diseases (Parathyroid Disorders)
01/2008
1Pheochromocytoma
10/2007
1Intestinal Polyps
07/2002
1Colorectal Neoplasms (Colorectal Cancer)
07/2002
1Polyps
07/2002

Drug/Important Bio-Agent (IBA)

9Parathyroid Hormone (Parathormone)IBA
12/2015 - 01/2008
6CalciumIBA
07/2015 - 07/2006
3papillary Thyroid cancerIBA
06/2015 - 09/2008
1Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
06/2015
1Phosphotransferases (Kinase)IBA
06/2015
1Har(29)- Arg(28) Nle(27) Orn(21) His(20) Orn(12,) Abu(15) His(11) Tyr(Me)(10) Har(9) Ala(8) Fpa(5,6) Arg(2) (PhAc-Ada)(0)-Tyr(1) GHRH(1-29)NH2IBA
06/2015
1Factor IX (PTC)FDA LinkGeneric
06/2015
1Dihydrotachysterol (AT 10)IBA
09/2013
1LithiumIBA
07/2009
13-Iodobenzylguanidine (Iobenguane)IBA
10/2007
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
07/2002
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2002
1rofecoxib (Vioxx)FDA Link
07/2002

Therapy/Procedure

14Parathyroidectomy
12/2015 - 12/2007
5Thyroidectomy
09/2013 - 09/2008
2Adrenalectomy
09/2013 - 10/2007
1Neck Dissection (Radical Neck Dissection)
12/2012